Pathophysiology of joint pain

Annals of the Rheumatic Diseases

Volumn 55, Issue 5, 1996, Pages 276-283

  Kidd, Bruce L ^a   Morris, Vanessa H ^a   Urban, Laszlo ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Sandoz Institute for Medical Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; IBUPROFEN; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROKININ ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ARTHRALGIA; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030004286     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.5.276     Document Type: Review

References (100)

1. McMahon S B, Koltzenburg M. Novel classes of nociceptors: beyond Sherrington. Trends Neurosci 1990; 13: 199-201.
2. Raja S N, Meyer R A, Campbell J N. Peripheral mechanisms of somatic pain. Anesthesiology 1988; 68: 571-90.
3. Rang H P, Bevan S, Dray A. Nociceptive peripheral neurones: cellular properties. In: Wall P D, Melzac M, eds. Textbook of pain, 3rd Edn. Edinburgh: Churchill Livingstone, 1994; 57-78.
4. Schaible H, Grubb B D. Afferent and spinal mechanisms of joint pain. Pain 1993; 55: 5-54.
5. Lynn B. The fibre composition of cutaneous nerves and the classification and response properties of cutaneous afferents, with particular reference to nociception. Pain Reviews 1994; 1: 172-83.
6. Freeman M A R, Wyke B. The innervation of the knee joint. An anatomical and histological study in the cat. J Anat 1967; 101: 505-32.
7. Langford L A, Schmidt R F. Afferent and efferent axons in the medial and posterior articular nerves of the cat. Anat Rec 1983; 206: 71-8.
8. Heppleman B, Heuss C, Schmidt R F. Fibre size distribution of myelinated and unmyelinated axons in the medial and posterior articular nerves of the cat's knee joint. Somatosens Res 1988; 5: 267-75.
9. Gronblad M, Konntinen Y T, Korkala O, Liesi P, Hukkanen M, Polak J. Neuropeptides in the synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1988; 15: 1807-10.
10. Mapp P I, Kidd B L, Gibson S J, et al. Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in the normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 1990; 37: 143-53.
11. Schaible H, Schmidt R F. Responses of fine medial articular nerve afferents to passive movements of knee joint. J Neurophysiol 1983; 49: 1118-26.
12. Schaible H, Schmidt R F. Time course of mechano-sensitivity changes in articular afferents during a developing experimental arthritis. J Neurophysiol 1988; 60: 2180-95.
13. Grigg P, Schaible H, Schmidt R F. Mechanical sensitivity of group III and IV afferents from posterior articular nerve in normal and inflamed cat knee. J Neurophysiol 1986; 55: 635-43.
14. Rang H P, Bevan S, Dray A. Chemical activation of nociceptive peripheral neurones. Br Med Bull 1991; 47: 534-48.
15. 2-induced activation and sensitization of articular mechanociceptors. Neurosci Lett 1991; 124: 5-8.
16. Taiwo Y O, Bjerknes L, Goetzl E, Levine J D. Mediation of primary afferent hyperalgesia by the cAMP second messenger system. Neuroscience 1989; 32: 577-80.
17. Malmberg A B, Yaksh T L. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 1993; 79: 270-81.
18. Kanaka R, Schaible H, Schmidt R F. Activation of fine articular afferent units by bradykinin. Brain Res 1985; 327: 81-90.
19. Davis A J, Perkins M N. Induction of B1 receptors in vivo in a model of persistent inflammatory hyperalgesia in the rat. Neuropharmacology 1994; 33: 127-33.
20. 1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br J Pharmacol 1994; 113: 940-4.
21. Thayer S A, Perney T M, Miller R J. Regulation of calcium homeostasis in sensory neurones by bradykinin. J Neurosci 1988; 8: 4089-97.
22. Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci 1993; 13: 99-104.
23. Bevan S, Geppetti P. Protons: small stimulants of capsaicin-sensitive sensory nerves. Trends Neurosci 1994; 17: 509-12.
24. Steen K H, Reeh P W, Anton F, Handwerker H O. Protons selectively induce long lasting excitation and sensitization to mechanical stimulation of nociceptors in rat skin, in vitro. J Neurosci 1992; 12: 86-95.
25. Kessler W, Kirchoff C, Reeh P W, Handwerker H O. Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P. Exp Brain Res 1992; 91: 467-76.
26. Stein C, Hassan A H S, Prezewlocki R, Gramsch C, Peter K, Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 1990; 87: 5935-9.
27. Stein C. Peripheral mechanisms of opioid analgesia. Anesth Analg 1993; 76: 182-91.
28. Stein C, Comisel K, Haimerl E, et al. Analgesic effect of intra-articular morphine after arthroscopic knee surgery. N Engl J Med 1991; 325: 1123-6.
29. Levine J D, Fields H L, Basbaum A L. Peptides and the primary afferent nociceptor. J Neurosci 1993; 13: 2273-86.
30. Wall P D, Gutnick M. Ongoing activity in peripheral nerves: the physiology and pharmacology of impulses originating from a neuroma. Exp Neurol 1974; 43: 580-93.
31. Devor M. Nerve pathophysiology and mechanisms of pain in causalgia. J Auton Nerv Syst 1983; 7: 371-84.
32. Bennet G J. The role of the sympathetic nervous system in painful peripheral neuropathy. Pain 1991; 45: 221-3.
33. Hu S, Zhu J. Sympathetic facilitation of sustained discharges of polymodal nociceptors. Pain 1989; 38: 85-90.
34. Wood J N, Winter J, James I F, Rang H P, Yeats J, Bevan S J. Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture. J Neurosci 1988; 8: 3208-20.
35. Lynn B. Capsaicin: actions on nociceptive C-fibres and therapeutic potential. Pain 1990; 41: 61-9.
36. Perkins M, Dray A. Novel pharmacological strategies for analgesia. Ann Rheum Dis 1996; 55: In press.
37. Bayliss W M. On the origin from the spinal cord of the vasodilator fibres of the hind limb and on the nature of these fibres. J Physiol (Lond) 1901; 26: 173-209.
38. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988; 24: 739-68.
39. Foreman J C. Peptides and neurogenic inflammation. Br Med Bull 1987; 43: 386-400.
40. LeVasseur S A, Gibson S J, Helme R D. The measurement of capsaicin-sensitive sensory nerve fibre function in elderly patients with pain. Pain 1990; 41: 19-25.
41. Helme R D, Littlejohn G O, Weinstein C. Neurogenic flare responses in chronic rheumatic pain syndromes. Clin Exp Neurol 1987; 23: 91-4.
42. Jolliffe V A, Anand P, Kidd B L. Assessment of cutaneous sensory and autonomic axon reflexes in rheumatoid arthritis. Ann Rheum Dis 1995; 54: 251-5.
43. Pernow B. Substance P. Pharmacol Rev 1983; 35: 85-141.
44. Donaldson L F, Harmar A J, McQueen D S, Secki J R. Increased expression of preprotachykinin, calcitonin gene-related peptide, but not vasoactive intestinal peptide messenger RNA in dorsal root ganglia during the development of adjuvant monarthritis in the rat. Brain Res Mol Brain Res 1992; 16: 143-9.
45. Garrett N E, Kidd B L, Cruwys S C, Tomlinson D R. Changes in preprotachykinin mRNA expression and substance P levels in dorsal root ganglia of monoarthritic rats: Comparison with changes in synovial substance P levels. Brain Res 1995; 675: 203-7.
46. Mapp P I, Kidd B L. Substance P in rheumatic disease. Semin Arthritis Rheum 1994; 6 (suppl 3): 3-9.
47. Ferrell W R, Russell N J W. Extravasation in the knee induced by antidromic stimulation of articular C fibre afferents of the anaesthetised cat. J Physiol (Lond) 1986; 379: 407-16.
48. Lam F Y, Ferrell W R. Effects of interactions of naturally-occurring neuropeptides on blood flow in the rat knee joint. Br J Pharmacol 1993; 108: 694-9.
49. Cruwys S C, Kidd B L, Mapp P I, Walsh D A, Blake D R. The effects of calcitonin gene-related peptide on formation of intra-articular oedema by inflammatory mediators. Br J Pharmacol 1992; 107: 116-9.
50. Lam F Y, Ferrell W R. Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist. Ann Rheum Dis 1989; 48: 928-32.
51. Lindsay R M, Harmar A J. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurones. Nature 1989; 337: 362-4.
52. Lewin G R, Mendell L M. Nerve growth factor and nociception. Trends Neurosci 1993; 16: 353-8.
53. Woolf C J, Safieh-Garabedian B, Ma Q P, Crilly P, Winters J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994; 62: 327-31.
54. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992; 49: 693-8.
55. Aloe L, Turveri M A, Carcassi U, Levi-Montalcini R. Nerve growth factor in synovial fluid of patients with chronic arthritis. Arthritis Rheum 1992; 35: 351-5.
56. McMahon S B, Bennett D L, Priestley J V, Shelton D L. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nature Medicine 1995; 1: 774-80.
57. Colpaert F C, Donnerer J, Lembeck F. Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis. Life Sci 1983;32:1827-34.
58. Levine J D, Dardick S J, Roizen M F, Helms C. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 1986; 6: 3423-9.
59. Cruwys S C, Garrett N E, Kidd B L. Sensory denervation with capsaicin attenuates inflammation and nociception in arthritic rats. Neurosci Lett 1995; 193: 205-7.
60. Levine D J, Dardick S J, Roizen M F, Basbaum A I, Scipio E. Reflex neurogenic inflammation. Contribution of the peripheral nervous system to spatially remote inflammatory responses that follow injury. J Neurosci 1985; 5: 1380-6.
61. Kidd B L, Cruwys S C, Garrett N E, Mapp P I, Jolliffe V A, Blake D R. Neurogenic influences on contralateral responses during experimental rat monarthritis. Brain Res 1995; 688: 72-6.
62. Sluka K A, Westlund K N. Centrally administered non-NMDA but not NMDA receptor antagonists block peripheral knee joint inflammation. Pain 1993; 55: 217-25.
63. Sluka K A, Jordan H H, Westlund K N. Reduction in joint swelling and hyperalgesia following post-treatment with a non-NMDA receptor antagonist. Pain 1994; 59: 95-100.
64. Sluka K A, Lawand N B, Westlund K N. Joint inflammation is reduced by dorsal rhizotomy and not by sympathectomy or spinal cord transection. Ann Rheum Dis 1994; 53: 309-14.
65. Lewis T. Pain. New York: MacMillan, 1942.
66. Hardy J D, Wolff H G, Goodell H. Experimental evidence on the nature of cutaneous hyperalgesia. J Clin Invest 1950; 29: 15-140.
67. Baumann T K, Simone D A, Shain C N, LaMotte R H. Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia. J Neurophysiol 1991; 66: 212-27.
68. LaMotte R H, Lundberg L E, Torebjork H E. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol (Lond) 1992; 448: 749-64.
69. Torejork H E, Lundeberg L, LaMotte R H. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol (Lond) 1992; 448: 765-80.
70. Lewis T, Kellgren J H. Observations relating to referred pain, viscero-motor reflexes and other associated phenomena. Clin Sci 1939; 4: 47-71.
71. Coderre T J, Katz J, Vaccarino A L, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52: 259-85.
72. Mendell L M, Wall P D. Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 1965; 206: 97-9.
73. Woolf C J. Evidence for a central component of postinjury pain hypersensitivity. Nature 1986; 308: 686-8.
74. Yoshimura M, Jessell T M. Primary afferent-evoked synaptic responses and slow potential generation in rat substantia gelatinosa in vitro. J Neurophysiol 1989; 62: 96-108.
75. Urban L, Thompson S W N, Nagy I, Dray A. Hyperexcitability in the spinal dorsal horn: cooperation of neuropeptides and excitatory amino acids. In: Urban L, ed. Cellular mechanisms of sensory processing. Berlin: Springer, 1994; 379-99.
76. Debiasi S, Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Prod Natl Acad Sci USA 1988; 85: 7820-4.
77. Coderre T J, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 1992; 40: 3665-70.
78. Urban L, Naeem S, Patel I A, Dray A. Tachykinin induced regulation of excitatory amino acid responses in the rat spinal cord in vitro. Neurosci Lett 1994; 168: 185-8.
79. Duggan A W, Hendry I A, Mortom C R, Hutchison W D, Zhao ZQ. Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res 1988; 451: 261-73.
80. Dougherty P M, Palecek J, Paleckova V, Willis W D. Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin. J Neurophysiol 1994; 72: 1464-75.
81. Rees H, Sluka K A, Tsuruoka M, Chen P S, Willis W D. The effects of NK1 and NK2 receptor antagonists on the sensitization of STT cells following acute inflammation in the anaesthetized primate. J Physiol (Lond) 1995; 483: 125P.
82. Yamamoto T, Yaksh T L. Stereospecific effects of a non-peptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Sci 1991; 49: 1955-63.
83. Thompson S W N, Gerber G, Sivilotti L G, Woolf C J. Long duration ventral root potentials in the neonatal rat spinal cord in vitro; the effects of ionotropic and metabotropic excitatory amino acide receptor antagonists. Brain Res 1992; 595: 87-97.
84. Haley J E, Sullivan A F, Dickenson A H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 1990; 518: 218-26.
85. Schaible H G, Grubb B D, Neugebauer V, Oppmann M. The effects of NMDA antagonists on neuronal activity in cat spinal cord evoked by acute inflammation in the knee joint. J Neurosci 1991; 3: 981-91.
86. Neugebauer V, Lücke T, and Schaible H-G. Differential effects of N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists on the responses of rat spinal neurons with joint input. Neurosci Lett 1993; 155: 29-32.
87. Neugebauer V, Lücke T, Schaible H-G. N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J Neurophysiol 1993; 70: 1365-77.
88. Thompson S W N, Dray A, Urban L. Injury-induced plasticity of spinal reflex activity: NK1 neurokinin receptor activation and enhanced A- and C-fiber mediated responses in the rat spinal cord in vitro. J Neurosci 1994; 14: 3672-87.
89. Rusin K I, Ryu P D, Randic M. Modulation of excitatory amino acid responses in rat dorsal horn neurones by tachykinins. J Neurophysiol 1992; 68: 265-86.
90. Malmberg A B, Yaksh T L. Hyperalgesia mediated by spinal glutamate or SP receptor blocked by spinal cyclooxygenase inhibition. Science 1992; 257: 1276-9.
91. Malmberg A B, Yaksh T L. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263: 136-46.
92. Malmberg A B, Yaksh T L. Cyclooxygenase inhibition and the spinal release of prostaglandin E, and amino acids evoked by paw formalin injection: A microdialysis study in unanesthetised rats. J Neurosci 1995; 15: 2768-76.
93. Chapman V, Dickenson A H. The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat. Eur J Pharmacol 1992; 219: 427-33.
94. Brune K, Beck W S, Geisslinger G, Menzel-Soglowek S, Peskar B M, Peskar B A. Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia 1991; 47: 257-61.
95. McMahon S B, Lewin G R, Wall P D. Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol 1993; 3: 602-10.
96. Woolf C J. Generation of acute pain: Central mechanisms. Br Med Bull 1991; 47: 523-33.
97. Woolf C J, King A E. Subthreshold components of the cutaneous mechanoreceptive fields of dorsal horn neurones in the rat lumbar spinal cord. J Neurophysiol 1989; 62: 907-16.
98. Morris V H, Cruwys S C, Kidd B L. Evidence for a central component to pain in rheumatoid arthritis. Br J Rheumatol 1996. In press.
99. Schaible H, Schmidt R F, Willis W D. Convergent inputs from articular, cutaneous and muscle receptors onto ascending tract cells in the cat spinal cord. Exp Brain Res 1987; 66: 479-88.
100. Grubb B D, Stiller R U, Schaible H G. Dynamic changes in the receptive field properties of spinal cord neurones with ankle input in rats with unilateral adjuvant-induced inflammation in the ankle region. Exp Brain Res 1992; 92: 441-52.